Suppr超能文献

系统性硬化症患者的眼部表现。

Ocular findings in patients with systemic sclerosis.

机构信息

Ophthalmology Department, Federal University of Rio de Janeiro, RJ, Brazil.

出版信息

Clinics (Sao Paulo). 2011;66(3):379-85. doi: 10.1590/s1807-59322011000300003.

Abstract

OBJECTIVE

To evaluate the frequency and characteristics of ocular manifestations in outpatients with systemic sclerosis.

METHODS

In this cross-sectional study, 45 patients with systemic sclerosis were enrolled. Data regarding demographics, disease duration and subtype, age at diagnosis, nailfold capillaroscopic pattern and autoantibody profile were collected, and a full ophthalmic examination was conducted. Parametric (Student's t-test) and nonparametric (Mann-Whitney U test) tests were used to compare continuous variables. Fisher's exact test was used to compare categorical data. P values < 0.05 were considered significant.

RESULTS

Twenty-three subjects (51.1%) had eyelid skin changes; 22 (48.9%) had keratoconjunctivitis sicca, 19 (42.2%) had cataracts, 13 (28.9%) had retinal microvascular abnormalities and 6 (13.3%) had glaucoma. Eyelid skin changes were more frequent in patients with the diffuse subtype of systemic sclerosis and were associated with a younger age and an earlier age at diagnosis. Cataracts were presumed to be age-related and secondary to corticosteroid treatment. There was no association between demographic, clinical or serological data and keratoconjunctivitis sicca. The retinal microvascular abnormalities were indistinguishable from those related to systemic hypertension and were associated with an older age and a severe capillaroscopic pattern.

CONCLUSIONS

Eyelid skin abnormalities and keratoconjunctivitis sicca were the most common ocular findings related to systemic sclerosis. Some demographic and clinical data were associated with some ophthalmic features and not with others, showing that the ocular manifestations of systemic sclerosis are characterized by heterogeneity and reflect the differences in the implicated pathophysiological mechanisms.

摘要

目的

评估系统性硬化症门诊患者眼部表现的频率和特征。

方法

在这项横断面研究中,共纳入 45 例系统性硬化症患者。收集了人口统计学、疾病持续时间和亚型、诊断时年龄、甲襞毛细血管镜模式和自身抗体谱的数据,并进行了全面的眼科检查。使用参数(Student's t 检验)和非参数(Mann-Whitney U 检验)检验比较连续变量。使用 Fisher 确切检验比较分类数据。P 值<0.05 被认为具有统计学意义。

结果

23 例(51.1%)患者有眼睑皮肤改变;22 例(48.9%)有干燥性角结膜炎,19 例(42.2%)有白内障,13 例(28.9%)有视网膜微血管异常,6 例(13.3%)有青光眼。弥漫性系统性硬化症患者的眼睑皮肤改变更为常见,且与更年轻的年龄和更早的诊断年龄相关。白内障被认为是与年龄相关的,继发于皮质类固醇治疗。在人口统计学、临床或血清学数据与干燥性角结膜炎之间没有关联。视网膜微血管异常与与系统性高血压相关的异常无法区分,且与年龄较大和严重的毛细血管镜模式相关。

结论

眼睑皮肤异常和干燥性角结膜炎是与系统性硬化症相关的最常见眼部表现。一些人口统计学和临床数据与某些眼部特征相关,而与其他特征不相关,这表明系统性硬化症的眼部表现具有异质性,并反映了所涉及的病理生理机制的差异。

相似文献

1
Ocular findings in patients with systemic sclerosis.
Clinics (Sao Paulo). 2011;66(3):379-85. doi: 10.1590/s1807-59322011000300003.
2
A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis.
Ocul Immunol Inflamm. 2021 Jan 2;29(1):81-89. doi: 10.1080/09273948.2019.1657467. Epub 2019 Oct 2.
3
Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?
Int Ophthalmol. 2018 Feb;38(1):251-256. doi: 10.1007/s10792-017-0454-1. Epub 2017 May 6.
4
Ophthalmic manifestations in patients with collagen vascular disorders: a hospital-based retrospective observational study.
Int Ophthalmol. 2021 Aug;41(8):2765-2775. doi: 10.1007/s10792-021-01833-x. Epub 2021 Apr 8.
5
Evaluation of dry eye signs and symptoms in patients with systemic sclerosis.
Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):1051-6. doi: 10.1007/s00417-012-1938-3. Epub 2012 Feb 18.
6
7
Ocular involvement in scleroderma.
Br J Ophthalmol. 1979 Dec;63(12):845-7. doi: 10.1136/bjo.63.12.845.
8
Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye.
Semin Arthritis Rheum. 2019 Aug;49(1):119-125. doi: 10.1016/j.semarthrit.2018.12.007. Epub 2018 Dec 28.
10
Profile of ocular and systemic characteristics in Möbius sequence patients from Brazil and Italy.
Arq Bras Oftalmol. 2012 May-Jun;75(3):202-6. doi: 10.1590/s0004-27492012000300011.

引用本文的文献

1
Utilizing Shear Wave Elastography for the Evaluation of Ocular Involvement in Systemic Sclerosis.
Diagnostics (Basel). 2025 May 13;15(10):1227. doi: 10.3390/diagnostics15101227.
2
Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review.
J Scleroderma Relat Disord. 2025 Jan 8:23971983241308050. doi: 10.1177/23971983241308050.
3
Ophthalmologic Implications of Connective Tissue Diseases: A Comprehensive Review of Current Knowledge and Innovations.
Cureus. 2024 Aug 17;16(8):e67078. doi: 10.7759/cureus.67078. eCollection 2024 Aug.
4
Dacryoadenitis associated with linear scleroderma : A case report and review of literature.
Skin Health Dis. 2024 Apr 22;4(4):e391. doi: 10.1002/ski2.391. eCollection 2024 Aug.
5
Ocular Manifestation in Systemic Sclerosis-A Literature Review.
Life (Basel). 2024 May 13;14(5):627. doi: 10.3390/life14050627.
6
Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis.
J Clin Med. 2024 May 7;13(10):2738. doi: 10.3390/jcm13102738.
7
Ophthalmologic profile of patients with systemic sclerosis.
Indian J Ophthalmol. 2024 Aug 1;72(8):1192-1198. doi: 10.4103/IJO.IJO_2980_23. Epub 2024 Apr 16.
9
Thickness of anterior sclera and corneal layers in systemic sclerosis.
Int Ophthalmol. 2024 Mar 15;44(1):137. doi: 10.1007/s10792-024-03013-z.
10
Ocular involvement in rheumatic diseases.
Reumatologia. 2023;61(5):389-394. doi: 10.5114/reum/172767. Epub 2023 Oct 31.

本文引用的文献

1
The prevalence of age-related macular degeneration and associated risk factors.
Arch Ophthalmol. 2010 Jun;128(6):750-8. doi: 10.1001/archophthalmol.2010.92.
3
Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
J Dermatol. 2010 Jan;37(1):42-53. doi: 10.1111/j.1346-8138.2009.00762.x.
4
Mechanisms of skin fibrosis in systemic sclerosis.
J Dermatol. 2010 Jan;37(1):11-25. doi: 10.1111/j.1346-8138.2009.00738.x.
7
Skin disease: a cardinal feature of systemic sclerosis.
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii14-8. doi: 10.1093/rheumatology/kep108.
8
[Frequency of lesions suggestive of ocular toxoplasmosis among a rural population in the State of Rio de Janeiro].
Rev Soc Bras Med Trop. 2009 Mar-Apr;42(2):165-9. doi: 10.1590/s0037-86822009000200014.
9
Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment.
Ocul Surf. 2009 Apr;7(2 Suppl):S1-S14. doi: 10.1016/s1542-0124(12)70620-1.
10
Ocular manifestations of scleroderma.
Surv Ophthalmol. 2009 Mar-Apr;54(2):292-304. doi: 10.1016/j.survophthal.2008.12.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验